×
Adocia Total Assets 2016-2023 | ADOCY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Adocia total assets from 2016 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
View More
Adocia Total Assets 2016-2023 | ADOCY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Adocia total assets from 2016 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
Related Stocks
Company Name
Market
Cap
Amgen (AMGN)
$148.2B
Vertex Pharmaceuticals (VRTX)
$120.8B
Bristol Myers Squibb (BMY)
$117.9B
Gilead Sciences (GILD)
$115.1B
CSL (CSLLY)
$87.1B
Regeneron Pharmaceuticals (REGN)
$85.5B
GSK (GSK)
$73B
Argenex SE (ARGX)
$36.8B
Alnylam Pharmaceuticals (ALNY)
$32.7B
BioNTech SE (BNTX)
$27.8B
Illumina (ILMN)
$23.6B
Biogen (BIIB)
$22.8B
BeiGene (BGNE)
$18.3B
Moderna (MRNA)
$16B
Genmab (GMAB)
$14.4B
Incyte (INCY)
$14B
Insmed (INSM)
$13B
BioMarin Pharmaceutical (BMRN)
$12.7B
Bio-Techne Corp (TECH)
$12.3B
Sarepta Therapeutics (SRPT)
$12.1B
Exact Sciences (EXAS)
$11.4B
Vaxcyte (PCVX)
$11.3B
QIAGEN (QGEN)
$10.5B
Exelixis (EXEL)
$10.1B
Bio-Rad Laboratories (BIO.B)
$9.4B
Intra-Cellular Therapies (ITCI)
$8.8B
Roivant Sciences (ROIV)
$8.8B
Repligen (RGEN)
$8.5B
Revolution Medicines (RVMD)
$8B
Ascendis Pharma (ASND)
$7.9B